Skip to content

Identification of Pathogens in the Neonatal Intensive Care Unit (NICU)

Identification of Pathogens and Their Antibiogram in the Neonatal Intensive Care Unit (NICU)

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03077100
Enrollment
2000
Registered
2017-03-10
Start date
2017-03-31
Completion date
2018-03-31
Last updated
2017-03-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pathogen Resistance

Brief summary

To aim of this study is to identify the pathogens and their distribution in the NICU and to determine whether empirical antibiotics are suitable for the treatment of sepsis in the unit.

Interventions

OTHERLaboratory identification of positive cultures

Laboratory identification of positive cultures

Sponsors

Hillel Yaffe Medical Center
Lead SponsorOTHER_GOV

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
No minimum to 3 Months
Healthy volunteers
No

Inclusion criteria

* Newborns with positive cultures

Exclusion criteria

\-

Design outcomes

Primary

MeasureTime frameDescription
AntibiogramOne yearPositive cultures will be examined using an antibiogram and pathogens will be identified

Countries

Israel

Contacts

Primary ContactSamah Abu-Fanni, MD
samah_af88@hotmail.com

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026